{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:20:06Z","timestamp":1772090406163,"version":"3.50.1"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021316","name":"AstraZeneca United States","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>In the Asia-Pacific region, there is limited data on the full extent of the burden of severe asthma, as well as a lack of clear guidance on improving care standards. Genetic, environmental, behavioural, policy and funding factors in -Asia-Pacific region differ from other parts of the world. To address these gaps, a panel of Asian experts conducted a comprehensive review of the existing literature in the region, aiming to understand the burden of severe asthma and provide key recommendations and actionable steps to improve its management across Asia. Experts identified several key challenges in managing SA, which include inadequate expertise, delayed patient identification or referral, limited access to advanced diagnostics and treatments, suboptimal adherence, and insufficient government support and funding, underlining the need for a more comprehensive approach to SA management. Experts also proposed that the Asia-Pacific region definition of clinical remission in SA should include elimination of exacerbation and use of oral corticosteroids, good symptom control, and inclusion of lung function criteria, particularly in light of the evolving treatment landscape. The experts concluded that while restoring normal lung function may be unrealistic for most patients with severe asthma and remodelled airways, striving for optimal individual lung function or maintaining stability may be a more attainable goal. Several key points and actionable recommendations were proposed to help reduce the overall burden of severe asthma in Asia.<\/jats:p>","DOI":"10.3389\/falgy.2026.1738118","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:53:16Z","timestamp":1772088796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding disease burden, challenges in current treatment strategies and call for action for management of severe asthma in Asia: a position statement from Asian respiratory experts"],"prefix":"10.3389","volume":"7","author":[{"given":"Mariko Siyue","family":"Koh","sequence":"first","affiliation":[{"name":"Respiratory and Critical Care Medicine, Singapore General Hospital","place":["Singapore, Singapore"]},{"name":"Duke- National University Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken Ka Pang","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong","place":["Shatin, New Territories, Hong Kong SAR, China"]},{"name":"Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong","place":["Shatin, New Territories, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Heon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hanyang University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Thi Tuyet","family":"Lan","sequence":"additional","affiliation":[{"name":"Respiratory Care Centre, University Medical Centre Ho Chi Minh City","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza","family":"Omar","sequence":"additional","affiliation":[{"name":"Respiratory Unit, Medical Department Hospital Raja Perempuan Zainab II","place":["Kota Bharu, Kelantan, Malaysia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thitiwat","family":"Sriprasart","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society","place":["Bangkok, Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Talwar","sequence":"additional","affiliation":[{"name":"Metro Centre for Respiratory Diseases","place":["Noida, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Lung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Far Eastern Memorial Hospital","place":["New Taipei City, Taiwan"]},{"name":"Department of Chemical Engineering and Materials Science, Yuan Ze University","place":["Taoyuan, Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.alit.2023.02.006","article-title":"Executive summary: Japanese guidelines for adult asthma (JGL) 2021","volume":"72","author":"Niimi","year":"2023","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3760\/cma.j.cn112137-20231117-01120","article-title":"[Chinese expert consensus on the diagnosis and management of severe asthma (2024 edition)]","volume":"104","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B5","year":"2025"},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/03007995.2018.1528218","article-title":"Uncontrolled severe asthma: starting from the unmet needs","volume":"35","author":"Caminati","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/thoraxjnl-2017-210531","article-title":"Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population","volume":"73","author":"Kerkhof","year":"2018","journal-title":"Thorax"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/jcm8091283","article-title":"Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management","volume":"8","author":"Kostakou","year":"2019","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccm.2005.10.005","article-title":"Corticosteroid therapy in asthma: predictors of responsiveness","volume":"27","author":"Mjaanes","year":"2006","journal-title":"Clin Chest Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/resp.14590","article-title":"Asthma in developing countries in the Asia-Pacific region (APR)","volume":"28","author":"Yasaratne","year":"2023","journal-title":"Respirol Carlton Vic"},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40101-021-00273-x","article-title":"Risk factors of asthma in the Asian population: a systematic review and meta-analysis","volume":"40","author":"Sio","year":"2021","journal-title":"J Physiol Anthropol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e14216","DOI":"10.1111\/pai.14216","article-title":"Climate change from the Asia-Pacific perspective: what an allergist needs to know and do","volume":"35","author":"Zain","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.3390\/ijerph17176212","article-title":"Impact of air pollution on asthma outcomes","volume":"17","author":"Tiotiu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B14","first-page":"364","article-title":"Update on asthma management guidelines","volume":"121","author":"Dubin","year":"2024","journal-title":"Mo Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2147\/JAA.S418145","article-title":"Global burden of asthma, and its impact on specific subgroups: nasal polyps, allergic rhinitis, severe asthma, eosinophilic asthma","volume":"16","author":"Rabe","year":"2023","journal-title":"J Asthma Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12890-023-02685-0","article-title":"Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Pulm Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"00122-2024","DOI":"10.1183\/23120541.00122-2024","article-title":"Epidemiology of patients with severe asthma in Japan: a nationwide descriptive study","volume":"10","author":"Kimura","year":"2024","journal-title":"ERJ Open Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.alit.2019.06.003","article-title":"Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4168\/aair.2017.9.1.52","article-title":"Asthma severity and the controller prescription in children at 12 tertiary hospitals","volume":"9","author":"Suh","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4168\/aair.2020.12.3.467","article-title":"Increasing prevalence and mortality of asthma with age in Korea, 2002\u20132015: a nationwide, population-based study","volume":"12","author":"Lee","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.12932\/AP-200220-0771","article-title":"Epidemiological, clinical and economic burden of severe eosinophilic asthma in Taiwan: results from a large tertiary care hospital","volume":"41","author":"Shantakumar","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5415\/apallergy.2014.4.2.75","article-title":"Epidemiology of adult asthma in Asia: toward a better understanding","volume":"4","author":"Song","year":"2014","journal-title":"Asia Pac Allergy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.5415\/apallergy.2020.10.e11","article-title":"Asia Pacific association of allergy asthma and clinical immunology white paper 2020 on climate change, air pollution, and biodiversity in Asia-Pacific and impact on allergic diseases","volume":"10","author":"Pawankar","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41533-019-0128-8","article-title":"A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan","volume":"29","author":"Inoue","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1440-1843.2004.00584.x","article-title":"Survey of asthma control in Thailand","volume":"9","author":"Boonsawat","year":"2004","journal-title":"Respirol Carlton Vic"},{"key":"B26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.47102\/annals-acadmedsg.V46N6p217","article-title":"Comparison of the proportion and healthcare utilisation of adult patients with uncontrolled severe asthma versus non-severe asthma seen in a southeast Asian hospital-based respiratory specialist clinic","volume":"46","author":"Tay","year":"2017","journal-title":"Ann Acad Med Singapore"},{"key":"B27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clinthera.2017.01.025","article-title":"Health care utilization and direct costs in mild, moderate, and severe adult asthma: a descriptive study using the 2014 South Korean health insurance database","volume":"39","author":"Lee","year":"2017","journal-title":"Clin Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/02770903.2018.1534967","article-title":"The prevalence and disease burden of severe eosinophilic asthma in Japan","volume":"56","author":"Tadao Nagasaki","year":"2019","journal-title":"J Asthma"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.vhri.2016.03.001","article-title":"Comparison of health care utilization and costs for patients with asthma by severity and health insurance in Thailand","volume":"9","author":"Dilokthornsakul","year":"2016","journal-title":"Value Health Reg Issues"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12932\/AP-210421-1118","article-title":"Guidelines for the management of asthma in adults: evidence and recommendations","volume":"40","author":"Kawamatawong","year":"2022","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/resp.13935","article-title":"Challenges faced in managing adult asthma: a perspective from Asian countries","volume":"25","author":"Dhar","year":"2020","journal-title":"Respirol Carlton Vic"},{"key":"B32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.resinv.2023.09.001","article-title":"Addressing therapeutic inertia for asthma biologics: lessons from the KOFU study","volume":"61","author":"Tamada","year":"2023","journal-title":"Respir Investig"},{"key":"B33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/lungindia.lungindia_518_23","article-title":"Call to action: addressing asthma diagnosis and treatment gaps in India","volume":"41","author":"Swarnakar","year":"2024","journal-title":"Lung India Off Organ Indian Chest Soc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/ijcm.IJCM_85_20","article-title":"Pediatric asthma: prevalence and socio-cultural factors affecting asthma management in a rural area of northern Karnataka","volume":"46","author":"Rashmi","year":"2021","journal-title":"Indian J Community Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3904\/kjim.2021.403","article-title":"The Korean severe asthma registry (KoSAR): real world research in severe asthma","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/02770900500265249","article-title":"Underrecognition of the severity of asthma and undertreatment of asthma in a rural area of Japan","volume":"42","author":"Tomita","year":"2005","journal-title":"J Asthma"},{"key":"B37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1067\/mai.2003.30","article-title":"Asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study","volume":"111","author":"Lai","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"00528","DOI":"10.1183\/23120541.00528-2021","article-title":"Prevalence, time trends and treatment practices of asthma in India: the global asthma network study","volume":"8","author":"Singh","year":"2022","journal-title":"ERJ Open Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4168\/aair.2021.13.3.507","article-title":"Specialist perception of severe asthma in Korea: a questionnaire survey","volume":"13","author":"Kim","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/lungindia.lungindia_432_22","article-title":"Biological therapy for severe asthma\u2014Indian perspectives and challenges","volume":"40","author":"Venkitakrishnan","year":"2023","journal-title":"Lung India"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.jacig.2023.100188","article-title":"Predictors of persistent poor control and validation of ASSESS score: longitudinal 5-year follow-up of severe asthma cohort","volume":"3","author":"Tiew","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"B42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/02770903.2020.1837158","article-title":"Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore","volume":"59","author":"Tan","year":"2022","journal-title":"J Asthma"},{"key":"B43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1081\/jas-100107122","article-title":"Hospital-based management of acute asthmatic exacerbation: an assessment of physicians\u2019 behavior in Taiwan","volume":"38","author":"Lee","year":"2001","journal-title":"J Asthma"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2147\/JAA.S468068","article-title":"Disease burden and access to biologic therapy in patients with severe asthma, 2017\u20132022: an analysis of the international severe asthma registry","volume":"17","author":"Le","year":"2024","journal-title":"J Asthma Allergy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1900804","DOI":"10.1183\/13993003.00804-2019","article-title":"Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study","volume":"54","author":"Lee","year":"2019","journal-title":"Eur Respir J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4168\/aair.2022.14.3.300","article-title":"Prescription patterns of oral corticosteroids for asthma treatment and related asthma phenotypes in university hospitals in Korea","volume":"14","author":"Kwon","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4168\/aair.2022.14.4.412","article-title":"Clinical characteristics and disease burden of severe asthma according to oral corticosteroid dependence: real-world assessment from the Korean severe asthma registry (KoSAR)","volume":"14","author":"Lee","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"108199","DOI":"10.1016\/j.rmed.2025.108199","article-title":"Ethnic variation in south east Asian patients with severe asthma: a first look at the Singapore severe asthma registry (SSAR) and implications on clinical practice","volume":"245","author":"Tay","year":"2025","journal-title":"Respir Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4168\/aair.2018.10.3.225","article-title":"Perceptions of severe asthma and asthma-COPD overlap syndrome among specialists: a questionnaire survey","volume":"10","author":"Kim","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2147\/JAA.S377174","article-title":"Characterization of patients in the international severe asthma registry with high steroid exposure who did or did not initiate biologic therapy","volume":"15","author":"Chen","year":"2022","journal-title":"J Asthma Allergy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jaip.2018.08.016","article-title":"Development of the international severe asthma registry (ISAR): a modified Delphi study","volume":"7","author":"Bulathsinhala","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-low and T2-high asthma phenotypes in real-life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/biomedicines11041226","article-title":"T2-low asthma: a discussed but still orphan disease","volume":"11","author":"Peri","year":"2023","journal-title":"Biomedicines"},{"key":"B54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4046\/trd.2023.0103","article-title":"Tailored biologics selection in severe asthma","volume":"87","author":"Kim","year":"2024","journal-title":"Tuberc Respir Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.12932\/AP-021222-1510","article-title":"Phenotype characterization and biomarker evaluation in moderate to severe type 2-high asthma","author":"Imoto","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.alit.2022.06.002","article-title":"Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: a nationwide cohort study in Japan (NHOM asthma study)","volume":"72","author":"Suzukawa","year":"2023","journal-title":"Allergol Int"},{"key":"B57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/JAA.S391970","article-title":"A multi-center study of the prevalence and characteristics of eosinophilic phenotype and high IgE levels among Chinese patients with severe asthma","volume":"16","author":"Ko","year":"2023","journal-title":"J Asthma Allergy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"CHEST"},{"key":"B59","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaip.2023.12.021","article-title":"Burden of uncontrolled severe asthma with and without elevated type-2 inflammatory biomarkers","volume":"12","author":"Ding","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/02770903.2021.1895208","article-title":"Characterization of uncontrolled, severe asthma patients with type 2 inflammation (T2): results from a physician survey across countries from Latin American, Eurasian Middle East regions and China","volume":"59","author":"Kosoy","year":"2022","journal-title":"J Asthma"},{"key":"B61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.alit.2019.02.004","article-title":"Severe asthma in Japan","volume":"68","author":"Nagase","year":"2019","journal-title":"Allergol Int"},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.alit.2020.06.002","article-title":"Clinical characteristics of patients with not well-controlled severe asthma in Japan: analysis of the keio severe asthma research program in Japanese population (KEIO-SARP) registry","volume":"70","author":"Tanosaki","year":"2021","journal-title":"Allergol Int"},{"key":"B63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/lungindia.lungindia_582_21","article-title":"A retrospective observational study on pheno-endotypes of severe asthma among adults attending asthma clinic in a tertiary care centre in India","volume":"39","author":"Talwar","year":"2022","journal-title":"Lung India"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1002\/ctm2.710","article-title":"Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohort","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4168\/aair.2024.16.4.338","article-title":"Comparison of asthma phenotypes in severe asthma cohorts (SARP, U-BIOPRED, ProAR and COREA) from 4 continents","volume":"16","author":"Park","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/JAA.S130459","article-title":"Sensitization to aspergillus species is associated with frequent exacerbations in severe asthma","volume":"10","author":"Goh","year":"2017","journal-title":"J Asthma Allergy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4168\/aair.2019.11.1.43","article-title":"Characteristics of adult severe refractory asthma in Korea analyzed from the severe asthma registry","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","article-title":"Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults","volume":"210","author":"Perez-de-Llano","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.resinv.2025.03.009","article-title":"Practical guidelines for asthma management (PGAM): digest edition","volume":"63","author":"Tamaoki","year":"2025","journal-title":"Respir Investig"},{"key":"B70","author":"Yamaguchi","year":"2024"},{"key":"B71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MCP.0000000000001068","article-title":"Remission in asthma","volume":"30","author":"Lommatzsch","year":"2024","journal-title":"Curr Opin Pulm Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s12325-022-02098-1","article-title":"Clinical remission in severe asthma: a pooled post hoc analysis of the patient journey with benralizumab","volume":"39","author":"Menzies-Gow","year":"2022","journal-title":"Adv Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1055\/a-2070-2135","article-title":"[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023\u2014published by the German respiratory society (DGP) e. \u200aV.]","volume":"77","author":"Lommatzsch","year":"2023","journal-title":"Pneumol Stuttg Ger"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1150162","DOI":"10.3389\/fimmu.2023.1150162","article-title":"Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study","volume":"14","author":"Pavord","year":"2023","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2400316","DOI":"10.1183\/13993003.00316-2024","article-title":"Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies","volume":"64","author":"Wechsler","year":"2024","journal-title":"Eur Respir J"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","article-title":"Severe asthma network Italy definition of clinical remission in severe asthma: a Delphi consensus","volume":"11","author":"Canonica","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1155\/2010\/318029","article-title":"Airway remodelling in asthma: from benchside to clinical practice","volume":"17","author":"Bergeron","year":"2010","journal-title":"Can Respir J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.alit.2020.08.001","article-title":"Japanese guidelines for adult asthma 2020","volume":"69","author":"Nakamura","year":"2020","journal-title":"Allergol Int"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.10.013","article-title":"Characteristics of severe asthma clinic patients with eosinophilic granulomatosis with polyangiitis","author":"Puan","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B80","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.resinv.2018.07.003","article-title":"Obesity-associated severe asthma in an adult Japanese population","volume":"56","author":"To","year":"2018","journal-title":"Respir Investig"},{"key":"B81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2332\/allergolint.14-RAI-0766","article-title":"Japanese guideline for adult asthma 2014","volume":"63","author":"Ohta","year":"2014","journal-title":"Allergol Int"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1164\/rccm.201911-2263OC","article-title":"Increased capsaicin sensitivity in patients with severe asthma is associated with worse clinical outcome","volume":"201","author":"Kanemitsu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2332\/allergolint.10-OA-0183","article-title":"Current situation of asthma therapy by allergists in primary medical facilities in Japan","volume":"59","author":"Ohbayashi","year":"2010","journal-title":"Allergol Int"},{"key":"B84","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaip.2025.01.006","article-title":"Relationships between chronic cough and asthma control and quality of life in patients with severe asthma: a 6-month longitudinal analysis","volume":"13","author":"Lee","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B85","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00408-024-00710-5","article-title":"Association of cough severity with asthma control and quality of life in patients with severe asthma","volume":"202","author":"Lee","year":"2024","journal-title":"Lung"},{"key":"B86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4103\/lungindia.lungindia_491_18","article-title":"Coexistence of allergic rhinitis and asthma in Indian patients: the CARAS survey","volume":"36","author":"Jaggi","year":"2019","journal-title":"Lung India"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/ALX02445E","article-title":"Asthma therapy concepts through the ages","volume":"8","author":"Lommatzsch","year":"2024","journal-title":"Allergol Sel"},{"key":"B88","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4168\/aair.2022.14.5.447","article-title":"Evolving concept of severe asthma: transition from diagnosis to treatable traits","volume":"14","author":"Park","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B90","doi-asserted-by":"publisher","first-page":"00024-2015","DOI":"10.1183\/23120541.00024-2015","article-title":"Management of the patient with eosinophilic asthma: a new era begins","volume":"1","author":"Groot","year":"2015","journal-title":"ERJ Open Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.intimp.2024.112189","article-title":"Precision medicine for severe asthma\u2014biological targeted therapy","volume":"134","author":"Sun","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12932\/AP0872","article-title":"Long-term effectiveness of omalizumab treatment in Thai severe asthmatic patients: a real-life experience","volume":"36","author":"Kawamatawong","year":"2018","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3904\/kjim.2020.549","article-title":"Effect of omalizumab as add-on therapy to quality of life questionnaire for Korean asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma","volume":"36","author":"Jung","year":"2021","journal-title":"Korean J Intern Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4168\/aair.2018.10.2.121","article-title":"Therapeutic effect of omalizumab in severe asthma: a real-world study in Korea","volume":"10","author":"Lee","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4168\/aair.2019.11.4.508","article-title":"Efficacy and safety of benralizumab for Korean patients with severe, uncontrolled eosinophilic asthma","volume":"11","author":"Park","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107611","article-title":"Benralizumab efficacy and safety in severe asthma: a randomized trial in Asia","volume":"107611","author":"Lai","year":"2024","journal-title":"Respir Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.alit.2024.10.009","article-title":"Effectiveness of benralizumab in the Tokyo asthma study (TOAST): a real-world prospective interventional trial","volume":"74","author":"Masaki","year":"2025","journal-title":"Allergol Int"},{"key":"B99","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3904\/kjim.2019.198","article-title":"Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4168\/aair.2024.16.4.372","article-title":"Long-term safety and efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Korean centers: a subgroup analysis of the phase 3 LIBERTY ASTHMA TRAVERSE trial","volume":"16","author":"Rhee","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/all.15711","article-title":"Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both","volume":"78","author":"Pfeffer","year":"2023","journal-title":"Allergy"},{"key":"B102","doi-asserted-by":"publisher","first-page":"230238","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur Respir Rev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1164\/rccm.202501-0246OC","article-title":"Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics","volume":"211","author":"Sadatsafavi","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.waojou.2020.100502","article-title":"Biologics and global burden of asthma: a worldwide portrait and a call for action","volume":"14","author":"Caminati","year":"2021","journal-title":"World Allergy Organ J"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/resp.14806","article-title":"Letter from Korea-oral corticosteroid stewardship in Korea: insights from the Korean severe asthma registry (KoSAR)","volume":"29","author":"Kang","year":"2024","journal-title":"Respirol Carlton Vic"},{"key":"B107","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2332\/allergolint.08-OA-0012","article-title":"Adherence with long-term asthma management in patients who experienced hospitalized asthma exacerbation","volume":"58","author":"Baba","year":"2009","journal-title":"Allergol Int"},{"key":"B108","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1744-8603-7-39","article-title":"A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries","volume":"7","author":"Moon","year":"2011","journal-title":"Glob Health"},{"key":"B109","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1377\/hlthaff.28.3.827","article-title":"Drug company\u2013sponsored patient assistance programs: a viable safety net?","volume":"28","author":"Choudhry","year":"2009","journal-title":"Health Aff (Millwood)"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1738118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:53:18Z","timestamp":1772088798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1738118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":109,"alternative-id":["10.3389\/falgy.2026.1738118"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1738118","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1738118"}}